Schlumberger Limited (SLB), an energy giant in the biotech market has been turning the heads of investors and hedge funds alike, due its becoming one of the best undervalued energy stocks in the market. Stock positions are increasing with stakeholders such as Principal Financial Group Inc, Syntax Research Inc, and several others. Despite a plummet of 30% YTD, analysts still believe in the immense upside potential of SLB, citing it as among the best fuel, natural gas, and crude oil stocks to buy. Opinions diverge on whether the current performance is underperformance in the energy sector or not but insiders are trading shares, signaling confidence in the company's prospects. Meanwhile, Jim Cramer lauds SLB as ‘The Best of Breed’ while voicing discontent on the slower-than-expected rise in stock. A SWOT analysis of SLB indicates that its future could hugely benefit from digital transformation while some investors still believe in its profit generation potential, sparking continuous buying and selling of the SLB shares. Schlumberger Limited is a promising and affordable stock according to hedge funds, and brokers still view SLB as a good investment.
Schlumberger Limited SLB News Analytics from Thu, 11 Jul 2024 07:00:00 GMT to Fri, 20 Dec 2024 21:27:52 GMT -
Rating 8
- Innovation 4
- Information 7
- Rumor 1
